Blind: Related Categories
Blind: Recent Articles
Multiple Dose Clinical Trial Of TorreyPines Therapeutics' Tezampanel Demonst 
0 Comments | Share | 178 Views | Problem? | 02/06/08
Linked From Medical News Today : TorreyPines Therapeutics, Inc. (Nasdaq: TPTX) announced that data from its multiple dose clinical trial of tezampanel, an antagonist of the AMPA and k
0 Comments | Share | 178 Views | Problem? | 02/06/08
Linked From Medical News Today : TorreyPines Therapeutics, Inc. (Nasdaq: TPTX) announced that data from its multiple dose clinical trial of tezampanel, an antagonist of the AMPA and k
Alexza Initiates AZ-007 (Staccato(R) Zaleplon) Phase 1 Clinical Trial And Up
0 Comments | Share | 87 Views | Problem? | 02/06/08
Linked From Medical News Today : Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) announced that it has initiated a Phase 1 clinical trial with AZ-007 (Staccato(R) zaleplon). AZ-007 is an
0 Comments | Share | 87 Views | Problem? | 02/06/08
Linked From Medical News Today : Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) announced that it has initiated a Phase 1 clinical trial with AZ-007 (Staccato(R) zaleplon). AZ-007 is an
Forest Laboratories, Inc. Announces Positive Results Of Memantine Study Of O
0 Comments | Share | 83 Views | Problem? | 02/06/08
Linked From Medical News Today : Forest Laboratories, Inc. (NYSE: FRX) announced preliminary results of a Phase III study of memantine HCl (currently marketed as Namenda(R), a twice-d
0 Comments | Share | 83 Views | Problem? | 02/06/08
Linked From Medical News Today : Forest Laboratories, Inc. (NYSE: FRX) announced preliminary results of a Phase III study of memantine HCl (currently marketed as Namenda(R), a twice-d
Multiple Dose Clinical Trial Of TorreyPines Therapeutics' Tezampanel Demonst
0 Comments | Share | 133 Views | Problem? | 02/06/08
Linked From Medical News Today : TorreyPines Therapeutics, Inc. (Nasdaq: TPTX) announced that data from its multiple dose clinical trial of tezampanel, an antagonist of the AMPA and k
0 Comments | Share | 133 Views | Problem? | 02/06/08
Linked From Medical News Today : TorreyPines Therapeutics, Inc. (Nasdaq: TPTX) announced that data from its multiple dose clinical trial of tezampanel, an antagonist of the AMPA and k
Novel Small Molecule Therapy Shows Benefit For Anemic Patients Via Hydration
0 Comments | Share | 75 Views | Problem? | 02/06/08
Linked From Medical News Today : Researchers are identifying innovative therapeutics for sickle cell anemia that focus on specific factors in the disease's progression, such as the im
0 Comments | Share | 75 Views | Problem? | 02/06/08
Linked From Medical News Today : Researchers are identifying innovative therapeutics for sickle cell anemia that focus on specific factors in the disease's progression, such as the im
Supplementary Approach To Malaria
0 Comments | Share | 46 Views | Problem? | 02/06/08
Linked From Medical News Today : Could a simple vitamin A and zinc supplement help protect young children from malaria? A randomized double blind trial reported in the open access publ
0 Comments | Share | 46 Views | Problem? | 02/06/08
Linked From Medical News Today : Could a simple vitamin A and zinc supplement help protect young children from malaria? A randomized double blind trial reported in the open access publ
Neuro-Hitech Reports Cognitive Improvement From Phase Two Clinical Trial Of
0 Comments | Share | 85 Views | Problem? | 02/06/08
Linked From Medical News Today : Neuro-Hitech, Inc. (NASDAQ: NHPI), a New York-based biopharmaceutical company focused on developing innovative drugs for the treatment of neurodegener
0 Comments | Share | 85 Views | Problem? | 02/06/08
Linked From Medical News Today : Neuro-Hitech, Inc. (NASDAQ: NHPI), a New York-based biopharmaceutical company focused on developing innovative drugs for the treatment of neurodegener
BioLineRx Announces Positive Results From Phase 2a Trial Of BL-1020, A GABA-
0 Comments | Share | 58 Views | Problem? | 02/06/08
Linked From Medical News Today : BioLineRx Ltd. (TASE:BLRX), a clinical stage drug development company, announced positive results from a Phase 2a trial of BL-1020, a GABA-enhanced an
0 Comments | Share | 58 Views | Problem? | 02/06/08
Linked From Medical News Today : BioLineRx Ltd. (TASE:BLRX), a clinical stage drug development company, announced positive results from a Phase 2a trial of BL-1020, a GABA-enhanced an
Supplementary Approach To Malaria
0 Comments | Share | 30 Views | Problem? | 02/06/08
Linked From Medical News Today : Could a simple vitamin A and zinc supplement help protect young children from malaria? A randomized double blind trial reported in the open access publ
0 Comments | Share | 30 Views | Problem? | 02/06/08
Linked From Medical News Today : Could a simple vitamin A and zinc supplement help protect young children from malaria? A randomized double blind trial reported in the open access publ
New Once Daily Salofalk Granules Launched For Ulcerative Colitis
0 Comments | Share | 33 Views | Problem? | 02/07/08
Linked From Medical News Today : Dr Falk Pharma launches once a day Salofalk granules, for the treatment of active ulcerative colitis. The Salofalk granules are a step forward in the t
0 Comments | Share | 33 Views | Problem? | 02/07/08
Linked From Medical News Today : Dr Falk Pharma launches once a day Salofalk granules, for the treatment of active ulcerative colitis. The Salofalk granules are a step forward in the t
Researchers Find Biological Factors That May Drive Prostate Tumor Aggressive
0 Comments | Share | 69 Views | Problem? | 02/07/08
Linked From Medical News Today : Researchers analyzing prostate tumors have identified differences in gene expression (the degree to which individual genes are turned on or off) betwe
0 Comments | Share | 69 Views | Problem? | 02/07/08
Linked From Medical News Today : Researchers analyzing prostate tumors have identified differences in gene expression (the degree to which individual genes are turned on or off) betwe
Nymox Announces Positive Results From New Multi-Center U.S. Study Of NX-1207
0 Comments | Share | 42 Views | Problem? | 02/08/08
Linked From Medical News Today : Nymox Pharmaceutical Corporation (NASDAQ:NYMX) announced that analysis of results from the Company's new multi-center U.S. Phase 2 Study NX02-0016 of
0 Comments | Share | 42 Views | Problem? | 02/08/08
Linked From Medical News Today : Nymox Pharmaceutical Corporation (NASDAQ:NYMX) announced that analysis of results from the Company's new multi-center U.S. Phase 2 Study NX02-0016 of
Fifth Annual International Bayada Award For Technological Innovation In Nurs
0 Comments | Share | 35 Views | Problem? | 02/08/08
Linked From Medical News Today : Drexel University College of Nursing and Health Professions (CNHP) announced the fifth annual Bayada Award for Technological Innovation in Nursing Ed
0 Comments | Share | 35 Views | Problem? | 02/08/08
Linked From Medical News Today : Drexel University College of Nursing and Health Professions (CNHP) announced the fifth annual Bayada Award for Technological Innovation in Nursing Ed
Data From Anthera's Plasma Trial To Be Presented As Late Breaker At American
0 Comments | Share | 44 Views | Problem? | 02/08/08
Linked From Medical News Today : Anthera Pharmaceuticals, Inc.
0 Comments | Share | 44 Views | Problem? | 02/08/08
Linked From Medical News Today : Anthera Pharmaceuticals, Inc.
New 48-Week Efficacy And Safety Data Presented For INTELENCE(TM) (etravirine
0 Comments | Share | 35 Views | Problem? | 02/08/08
Linked From Medical News Today : New data showed that at 48 weeks, significantly more treatment-experienced adults with HIV-1 with documented resistance to non-nucleoside reverse tra
0 Comments | Share | 35 Views | Problem? | 02/08/08
Linked From Medical News Today : New data showed that at 48 weeks, significantly more treatment-experienced adults with HIV-1 with documented resistance to non-nucleoside reverse tra
Labopharm Reports Positive Results For Phase III Study On Once-daily Trazodo
0 Comments | Share | 36 Views | Problem? | 02/09/08
Linked From Medical News Today : Labopharm Inc. (TSX: DDS; NASDAQ: DDSS) announced that its recently completed North American Phase III clinical trial for its once-daily formulation o
0 Comments | Share | 36 Views | Problem? | 02/09/08
Linked From Medical News Today : Labopharm Inc. (TSX: DDS; NASDAQ: DDSS) announced that its recently completed North American Phase III clinical trial for its once-daily formulation o
Study Suggests Risperidone Long-Acting Injection Combined With Standard Trea
0 Comments | Share | 132 Views | Problem? | 02/10/08
Linked From Medical News Today : Patients with frequently relapsing bipolar disorder had a significant delay in the time to an initial relapse when risperidone long-acting injection (
0 Comments | Share | 132 Views | Problem? | 02/10/08
Linked From Medical News Today : Patients with frequently relapsing bipolar disorder had a significant delay in the time to an initial relapse when risperidone long-acting injection (
Centocor Announces Ustekinumab Biologic License Application Accepted For Fil
0 Comments | Share | 69 Views | Problem? | 02/10/08
Linked From Medical News Today : Centocor, Inc. announced that the Biologics License Application (BLA) for ustekinumab (CNTO 1275) has been accepted for review by the U.S. Food and Dr
0 Comments | Share | 69 Views | Problem? | 02/10/08
Linked From Medical News Today : Centocor, Inc. announced that the Biologics License Application (BLA) for ustekinumab (CNTO 1275) has been accepted for review by the U.S. Food and Dr
New 48-Week Efficacy And Safety Data Presented For INTELENCEâ„¢ (Etravir
0 Comments | Share | 91 Views | Problem? | 02/10/08
Linked From Medical News Today : New data showed that at 48 weeks, significantly more treatment-experienced adults with HIV-1 with documented resistance to non-nucleoside reverse tran
0 Comments | Share | 91 Views | Problem? | 02/10/08
Linked From Medical News Today : New data showed that at 48 weeks, significantly more treatment-experienced adults with HIV-1 with documented resistance to non-nucleoside reverse tran
IPC Governing Board Statement on Combining of Sport Classes
0 Comments | Share | 245 Views | Problem? | 02/14/08
Linked From International Paralympic Committee Press Releases : read more...
0 Comments | Share | 245 Views | Problem? | 02/14/08
Linked From International Paralympic Committee Press Releases : read more...